Emily Field, head of European pharmaceuticals research at Barclays, weighs in on rising competition in the global obesity ...

Merck's latest earnings call revealed a mix of growth and pain points for the pharmaceutical giant.

A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.

The ability to probe the smallest building blocks of matter has long fascinated scientists, fueling advancements in medicine, ...

Conduit and Sarborg complete all milestones of Phase I of their AI-driven drug development collaboration, and commence transitioning to Phase II, ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer support for drug development customers. The acquisition of Pii enhances Jabil's ...

At the University of Oklahoma, Prof. Indrajeet Sharma is leading a team of scientists that is working on a ‘skeletal editing’ technique that allows repurposing of existing drugs to treat different ...

There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...

A groundbreaking cannabinoid-based antimicrobial, Silvanex, fights drug-resistant infections with a synergy of silver, CBC ...

Residents testified they were concerned about drug rehab patients wandering into Century Village late at night and breaking into condos.

As part of the foreign aid freeze by President Donald Trump, the U.S. distribution of HIV drugs in poor countries has been ...